Glycated hemoglobin in ST-elevation myocardial infarction without previously known diabetes: Its short and long term prognostic role

Glycated hemoglobin in ST-elevation myocardial infarction without previously known diabetes: Its short and long term prognostic role

Abstract In 518 consecutive STEMI non-diabetic patients, glycated hemoglobin > 6.5% was not associated with increased short and long term mortality, but was associated with higher admission glucose values, worse in-hospital glycemic control and a higher incidence of acute insulin resistance (HOMA...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes research and clinical practice 2012-01, Vol.95 (1), p.e14-e16
Hauptverfasser: Lazzeri, Chiara, Valente, Serafina, Chiostri, Marco, Picariello, Claudio, Attanà, Paola, Gensini, Gian Franco
Format: Artikel
Sprache:eng
Schlagworte:
Adult
Blood Glucose
Endocrinology & Metabolism
Glycated hemoglobin
Glycated Hemoglobin A - analysis
Hospital Mortality
Humans
Myocardial Infarction - blood
Myocardial Infarction - mortality
Non diabetic
Prognosis
STEMI
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract In 518 consecutive STEMI non-diabetic patients, glycated hemoglobin > 6.5% was not associated with increased short and long term mortality, but was associated with higher admission glucose values, worse in-hospital glycemic control and a higher incidence of acute insulin resistance (HOMA index).
ISSN:0168-8227
1872-8227
DOI:10.1016/j.diabres.2011.09.028